What is the Neogen Corporation stock price forecast?

Neogen Corporation is currently trading at $9.31. View real-time AI analysis on Alpha Lenz.

What is Neogen Corporation insider trading activity?

View the latest insider trading data for Neogen Corporation on Alpha Lenz.

What is Neogen Corporation's P/E ratio?

Neogen Corporation's P/E ratio is -1.9.

Neogen Corporation

NASDAQ · NEOG

$9.31+0.01(+0.11%)Pre-market

Ask about Neogen Corporation's future dividend policy...

Alpha Chat Insight

“Neogen Corporation trades at a P/E of -1.9 (undervalued) with modest ROE of -41.9%. 3Y revenue CAGR of 19.3% highlights clear growth momentum.”

Ask for details →

Company Overview

Neogen Corporation, a prominent global leader in food and animal safety solutions, primarily develops and markets products that enhance the safety of the food and animal industries. Their diverse product range encompasses diagnostic tests, vitamins, pharmaceuticals, disinfectants, and other hygiene solutions that ensure the safety and quality of food and animal health products. Neogen’s solutions are vital across agrochemical, veterinary, and food production sectors, impacting industries worldwide by promoting better safety and compliance standards. Established in 1981 and headquartered in Lansing, Michigan, Neogen has built a robust portfolio addressing issues from rapid pathogen detection to improving livestock productivity. This strategic focus on food safety and animal health positions Neogen Corporation as an essential player in mitigating risks in the global food supply chain, thus supporting public health and agricultural sustainability.

CEOMr. Mike Nassif

Websitehttps://www.neogen.com

SectorHealthcare

IndustryDiagnostics & Research

Employees2,974

Company Statistics

FY 2025

Profile

$2.02BMarket Cap

$894.66MRevenue

0.00Shares Out

2,974Employees

Margins

47.10%Gross

13.80%EBITDA

-0.19%Operating

-126.65%Pre-Tax

-122.06%Net

Valuation

-1.85P/E

0.98P/B

2.26EV/Sales

22.56EV/EBITDA

-43.60P/FCF

Growth (CAGR)

19.28%Rev 3Yr

16.43%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-27.33%ROA

-41.88%ROE

-26.56%ROIC

Financial Health

$129.00MCash & Cash Equivalents

$1.24BNet Debt

66.27%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Neogen Corporation trades at a P/E of -1.9 (undervalued) with modest ROE of -41.9%. 3Y revenue CAGR of 19.3% highlights clear growth momentum.”

Ask for details →

Frequently Asked Questions

Neogen Corporation (ticker: NEOG) is a company listed on NASDAQ in the Healthcare sector (Diagnostics & Research). It has approximately 2,974 employees. Market cap is $2.0B.

The current price is $9.31 with a P/E ratio of -1.85x and P/B of 0.98x.

ROE is -41.88% and operating margin is -0.19%. Annual revenue is $895M.